ResearcherSoochow UniversityNo recent work listed
Cheng Hang
Matched on OpenAlex author ID A5050379997. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 12
2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: 1 paper · 2023: 1 paper
Papers 4
- Lithium chloride induces apoptosis by activating endoplasmic reticulum stress in pancreatic cancer. Co-author DOI 10.1016/j.tranon.2023.101792↗
- β2-adrenergic receptor drives the metastasis and invasion of pancreatic ductal adenocarcinoma through activating Cdc42 signaling pathway. Co-author DOI 10.1007/s10735-022-10076-8↗
- Ubiquitin-specific protease 14 (USP14) promotes proliferation and metastasis in pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s10735-020-09934-0↗
- MiR-145 functions as a tumor suppressor via regulating angiopoietin-2 in pancreatic cancer cells. First author DOI 10.1186/s12935-016-0331-4↗
Closest collaborators
The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Jianxin Zhu · 3 shared papers, 2016–2022 · strength 0.38
- Paper Ubiquitin-specific protease 14 (USP14) promotes proliferation and metastasis in pancreatic ductal adenocarcinoma. DOI 10.1007/s10735-020-09934-0↗
- Paper β2-adrenergic receptor drives the metastasis and invasion of pancreatic ductal adenocarcinoma through activating Cdc42 … DOI 10.1007/s10735-022-10076-8↗
- Paper MiR-145 functions as a tumor suppressor via regulating angiopoietin-2 in pancreatic cancer cells. DOI 10.1186/s12935-016-0331-4↗
- Ying Lv · 1 shared paper, 2023 · strength 0.16
- Yixuan Zhang · 1 shared paper, 2023 · strength 0.16
- Hao Wu · 1 shared paper, 2023 · strength 0.16
- Shanshan Shen · 1 shared paper, 2023 · strength 0.16
- Shu Zhang · 1 shared paper, 2023 · strength 0.16
- Xiaoping Zou · 1 shared paper, 2023 · strength 0.16
- Gong Chen · 1 shared paper, 2022 · strength 0.15
- Haifeng Chen · 1 shared paper, 2022 · strength 0.15
- Ye Lu · 1 shared paper, 2022 · strength 0.15
- Hao Wang · 1 shared paper, 2016 · strength 0.06
- Xilong Ou · 1 shared paper, 2016 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.